Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Liver disease drug

A technology for drugs and liver diseases, which is applied in the field of chronic liver disease, drugs for the treatment of liver diseases such as hepatitis A, chronic liver disease and hepatitis C, and acute hepatitis B. It can solve the problems of easy recurrence and low negative conversion rate, and achieve the purpose of inhibiting virus replication and recurrence rate Low, stable efficacy

Active Publication Date: 2013-07-31
深圳市日月神生物科技股份有限公司
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But so far, the existing viral drugs such as interferon can indirectly kill the virus while increasing the antibody, the negative conversion rate is low, and it is easy to relapse

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liver disease drug
  • Liver disease drug
  • Liver disease drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] Example 1, the unit is gram, and the components of the liver disease medicine are as follows:

[0086]

[0087]

Embodiment 2

[0088] Example 2, the unit is gram, and the components of the liver disease medicine are as follows:

[0089]

Embodiment 3

[0090] Example 3, the unit is gram, and the components of the liver disease medicine are as follows:

[0091]

[0092]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a liver disease drug which is used for solving the technical problems of treating liver diseases including hepatitis A, acute hepatitis B, chronic persistent hepatitis, chronic active hepatitis and hepatitis C. The liver disease drug comprises the following components in parts by weight: 1-15000 parts of ants, 1-8000 parts of white atractylodes rhizomes, 0.5-9000 parts of cordyceps sinensis, 1-6000 parts of barbary wolfberry fruits, 1-6000 parts of astragalus mongholicus, 1-4500 parts of Chinese dates, 1-10000 parts of red-rooted salvia roots and 1-5000 parts of Chinese angelica. Compared with the prior art, the liver disease drug is directly absorbed and utilized by the organism in the form of enzyme while all active ingredients and active substances of the ants are kept for promoting hyperplasia of degenerated thymus gland and increasing the weight of degenerated thymus gland to generate interferon in an induced manner, so that white blood cells, T lymphocytes and lysozyme are increased, and therefore, the activity of the interleukin II in killing viruses is obviously enhanced, and hepatitis virus is killed and virus replication is restrained. Besides, the liver disease drug has the effects of nourishing liver and kidney, clearing away heat and toxic materials, soothing the liver and protecting the liver and strengthening the body resistance to eliminate pathogenic factors.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for treating liver diseases such as hepatitis A, acute hepatitis B, chronic liver disease, chronic liver disease and hepatitis C. Background technique [0002] According to the pathogenesis, liver diseases can be divided into viral liver diseases such as hepatitis A, hepatitis B, and C and non-viral liver diseases such as alcoholic liver and fatty liver. Due to factors such as diet, emotions, and external viral infections, liver lesions occur. According to incomplete statistics, there are more than 100 million people infected with hepatitis B virus and more than 20 million chronic hepatitis B patients in my country, which is a high incidence area of ​​hepatitis B. More than 80% of serious diseases such as liver cirrhosis and liver cancer in my country are developed from hepatitis B. Chronic hepatitis, mainly hepatitis B and C, is a serious progressive disease that currently affects the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/90A61K36/8998A61K36/815A61P1/16A61P31/14A61P31/20A61K35/64A61K35/56A61K35/586A61K35/618A61K35/644
CPCY02A50/30
Inventor 殷广全
Owner 深圳市日月神生物科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com